<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2021.749931</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Association Between Anatomical Location and Hematoma Expansion in Deep Intracerebral Hemorrhage</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Song</surname> <given-names>Lei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/749098/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Qiu</surname> <given-names>Xiao-Ming</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Guo</surname> <given-names>Ting-Ting</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhou</surname> <given-names>Hang</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tang</surname> <given-names>Dong-Fang</given-names></name>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Long-Sheng</given-names></name>
<xref ref-type="aff" rid="aff8"><sup>8</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fu</surname> <given-names>Yu-Fei</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Hui</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mao</surname> <given-names>Hua-Qing</given-names></name>
<xref ref-type="aff" rid="aff9"><sup>9</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Hai-Bao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/362335/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yu</surname> <given-names>Yong-Qiang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/312340/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Radiology, The First Affiliated Hospital of Anhui Medical University</institution>, <addr-line>Hefei</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Research Center of Clinical Medical Imaging</institution>, <addr-line>Hefei</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Anhui Provincial Institute of Translational Medicine</institution>, <addr-line>Hefei</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Radiology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group</institution>, <addr-line>Huangshi</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Radiology, Xiangyang No. 1 People&#x00027;s Hospital, Hubei University of Medicine</institution>, <addr-line>Xiangyang</addr-line>, <country>China</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Radiology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science</institution>, <addr-line>Xiangyang</addr-line>, <country>China</country></aff>
<aff id="aff7"><sup>7</sup><institution>Department of Neurosurgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science</institution>, <addr-line>Xiangyang</addr-line>, <country>China</country></aff>
<aff id="aff8"><sup>8</sup><institution>Department of Radiology, The Second Hospital of Anhui Medical University</institution>, <addr-line>Hefei</addr-line>, <country>China</country></aff>
<aff id="aff9"><sup>9</sup><institution>School of Computer Engineering, Hubei University of Arts and Science</institution>, <addr-line>Xiangyang</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Anna Bersano, IRCCS Carlo Besta Neurological Institute Foundation, Italy</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Christian Foerch, University Hospital Frankfurt, Germany; Archana Hinduja, The Ohio State University, United States</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Yong-Qiang Yu <email>cjr.yuyongqiang&#x00040;vip.163.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Stroke, a section of the journal Frontiers in Neurology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>02</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>749931</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>12</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Song, Qiu, Guo, Zhou, Tang, Wang, Fu, Chen, Mao, Wang and Yu.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Song, Qiu, Guo, Zhou, Tang, Wang, Fu, Chen, Mao, Wang and Yu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>To establish the relationship between hematoma sites of involvement and hematoma expansion (HE) in patients with deep intracerebral hemorrhage (ICH).</p>
</sec>
<sec>
<title>Methods</title>
<p>Eligible patients with deep ICH admitted to hospital within 6 hours of onset between 2018 and 2020 were included in this retrospective multi-center study. Individuals with secondary ICH were excluded. The volume of HE was evaluated based on admission and follow-up computed tomography scans. Associations between deep ICH sites of involvement and HE were examined using multivariable logistic regression analysis while adjusting for confounding covariates of HE.</p>
</sec>
<sec>
<title>Results</title>
<p>We enrolled 583 individuals from three stroke centers. Data from a final total of 460 patients were used in the analysis; of these patients, 159 (34.6%) had HE. In the crude model without adjustment, external capsule, anterior limb of the internal capsule, and posterior limb of the internal capsule (PLIC) involvement were correlated with HE. After fully adjusted models for sex, age, intraventricular hemorrhage, Glasgow Coma Scale admission score, baseline ICH volume, and time from onset to initial computed tomography, multivariable logistic regression revealed that the PLIC is a robust predictor of HE in patients with deep ICH (adjusted odds ratio = 2.73; 95% confidence interval = 1.75&#x02013;4.26; <italic>p</italic> &#x0003C; 0.001).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Involvement of the posterior limb of the internal capsule in deep hemorrhage could be a promising predictor of HE.</p>
</sec>
</abstract>
<kwd-group>
<kwd>intracerebral hemorrhage</kwd>
<kwd>hematoma expansion</kwd>
<kwd>deep</kwd>
<kwd>location</kwd>
<kwd>stroke</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="26"/>
<page-count count="7"/>
<word-count count="4626"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>The Global Burden of Disease 2019 study ranked stroke as the primary cause of disability-adjusted life years in those aged 50 years and older (<xref ref-type="bibr" rid="B1">1</xref>). Intracerebral hemorrhage (ICH) is one of the most devastating and fatal subtypes of cerebrovascular accidents, and is associated with mortality rates of up to 40% (<xref ref-type="bibr" rid="B2">2</xref>). Approximately 30% of patients with ICH will experience hematoma expansion (HE) within 6 hours after the onset of neurological deficits (<xref ref-type="bibr" rid="B3">3</xref>), and HE has long been deemed as an independent predictor for worse outcomes (<xref ref-type="bibr" rid="B4">4</xref>). Every 1 mL increase in a hematoma has been estimated to elevate the risk of death by 5% (<xref ref-type="bibr" rid="B5">5</xref>). Additionally, attempts to prevent HE are crucial in managing the early phase of ICH, and this is a potential target for hemostasis treatment (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). The timely detection of patients with ICH who have a high risk of hemorrhagic progression is therefore of great importance.</p>
<p>HE is associated with multiple factors, including Glasgow Coma Scale (GCS) score at admission, time from symptom onset to the first computed tomography (CT) scan, hemorrhage location, and initial hematoma volume (<xref ref-type="bibr" rid="B8">8</xref>). However, the relationship between hemorrhage location and HE deserves further investigation. Several studies have indicated that patient with deep ICH are more susceptible to HE than those with lobar ICH (<xref ref-type="bibr" rid="B9">9</xref>&#x02013;<xref ref-type="bibr" rid="B11">11</xref>). Nevertheless, the inclusion of hemorrhage location may have restricted the applicability of HE differences between lobar and deep groups, which have a different etiology. Spontaneous ICH is overwhelmingly driven by hypertensive angiopathy, especially in deep zones, whereas cerebral amyloid angiopathy is generally cited as the primary reason for ICH at lobar sites (<xref ref-type="bibr" rid="B12">12</xref>). However, the heterogeneity between these sites means that there is no sufficient evidence to suggest that HE is more frequently observed in deep ICH than in lobar ICH. Additionally, the basal ganglia-thalamic region has long been viewed as the most frequent site of hemorrhage (<xref ref-type="bibr" rid="B7">7</xref>); focusing on deep ICH may help to determine the mechanisms underlying HE.</p>
<p>Thus, additional exploration of the relationship between deep ICH location and HE is warranted. We hypothesized that specific sites of deep ICH affect HE. The current study was performed to test this hypothesis.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec>
<title>Study Design and Patient Selection</title>
<p>This multi-center, retrospective study was performed at three stroke centers (The First Affiliated Hospital of Anhui Medical University, The Second Hospital of Anhui Medical University, and Xiangyang Central Hospital) from January 2018 to December 2020. Consecutive patients aged &#x0003E;18 years with spontaneous ICH were approached. Eligible individuals were screened in light of the following inclusion criteria: (1) Spontaneous ICH was identified on CT; and (2) baseline CT scans and follow-up CT scans were acquired within 6 h and 48 h after the initial ictus, respectively. The exclusion criteria were as follows: (1) Primary intraventricular hemorrhage (IVH); (2) secondary ICH ascribed to aneurysm, congenital arteriovenous malformation, moyamoya, a tumor-related condition, or hemorrhagic transformation of cerebral infarction; (3) anticoagulant-associated ICH; (4) hematoma evacuation in previous follow-up CT scans; and/or (5) severe imaging artifacts during CT examinations.</p>
</sec>
<sec>
<title>Clinical Data Collection and Image Analysis</title>
<p>Demographic and clinical data were taken from electronic medical records. Data concerning demographics (age and sex), relevant medical conditions (prior ICH, ischemic stroke, hypertension, and diabetes mellitus), and clinical features (alcohol, smoking, international normalized ratio, blood pressure, initial GCS score, and time from symptom onset to first CT scan) were noted. Radiological findings, that is, parenchymal hematoma volume and location, and IVH, were evaluated using baseline and follow-up CT images. Deep ICH was further divided into 6 sites according to a previous study (<xref ref-type="bibr" rid="B13">13</xref>), comprising the globus pallidus/putamen (GP/P), anterior limb of the internal capsule (ALIC), external capsule (EC), posterior limb of the internal capsule (PLIC), caudate head, and thalamus. More than one area was reported in the case of hemorrhage that involved more than one site. If minor bleeding was confined to one region, the region were considered to be involved in ICH. For a well-demarcated GP/P, caudate head, and thalamus, implication of more than one-third of the structure was defined as involvement. When ALIC, PLIC, or EC were classified as affected, these regions were considered to be involved. All CT images were randomized and independently reviewed by two highly experienced neuroradiologists (Y-QY and X-MQ) who were blinded to the clinical data. For ambiguous cases or when opinions contradicted, the two neuroradiologists discussed together until they reached a rational conclusion.</p>
<p>Images from CT acquisition with an axial section thickness of 5 mm and no gaps were stored in Digital Imaging and Communications in Medicine format and then imported into the 3D Slicer software (version 4.11.20210226 <ext-link ext-link-type="uri" xlink:href="https://www.slicer.org/">https://www.slicer.org/</ext-link>). The hematoma was automatically segmented by setting a fixed threshold range (40&#x02013;100 HU), and the corresponding marked brain tissue or skull outside of the hemorrhage region was manually pruned using Erase tools. Manual layer-by-layer segmentations were performed to connect parenchymal hematomas and IVH hematomas. Finally, the hemorrhage volume was calculated by subtracting the initial CT from the follow-up CT. The criteria for HE were determined by referring to prior studies (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>), which included the following four types: parenchymal hematomas &#x02265;6 mL or &#x0003E;33% increase according to CT scans at admission and during follow-up; IVH expansion &#x02265;1 mL on comparison of follow-up and baseline CT scans; any new IVH expansions on follow-up CT scans.</p>
</sec>
<sec>
<title>Statistical Analyses</title>
<p>The Kolmogorov&#x02013;Smirnov test was applied to test the normality of data distribution. Normally distributed variables are expressed as the mean &#x000B1; standard deviation (SD), and non-normally distributed variables are expressed as the median &#x000B1; interquartile range. Categorical data are presented as percentages (%). Between-group differences were analyzed using Student&#x00027;s <italic>t</italic>-tests (or Mann&#x02013;Whitney <italic>U</italic>-tests) for continuous variables, and Chi-square (&#x003C7;<sup>2</sup>) tests (or Fisher&#x00027;s exact tests) for categorical variables, as appropriate.</p>
<p>The relevant risk factors for HE were identified using univariate analysis, and the odds ratio (OR) and confidence intervals (95% CIs) were calculated. The association between deep hematoma sites and HE were estimated using multivariable binary logistic regression models after adjusting for potential confounders, such as age, sex, time from symptom onset to initial CT scan, baseline hematoma volume, admission GCS score, and IVH, as informed by prior studies. We further explored the relationship between specific regions of deep hemorrhages and HE using stratification analysis. The standard level of statistical significance was determined at <italic>p</italic> &#x0003C; 0.05. All statistical analyses were performed using R software (version 4.0.3).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Subject Population and Characteristics</title>
<p>This retrospective study enrolled 583 individuals from three stroke centers. A total of 460 patients with deep ICH were enrolled in the analytic sample, of whom 159 (34.6%) had HE. We removed 123 patients for several reasons, as follows: infratentorial ICH (<italic>n</italic> = 44), lobar ICH (<italic>n</italic> = 70), and combined deep and lobar sites (<italic>n</italic> = 9). The flowchart of participant selection is presented in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref>.</p>
<p>Differences in baseline characteristics of deep ICH were notable between groups with and without HE. Patients with HE had worse GCS scores, had a shorter time from onset to CT, and had a larger baseline ICH volume than patients without HE (<italic>p</italic> &#x0003C; 0.05). No clinically relevant disparities in demographic characteristics or medical history were noted. Similarly, there were no remarkable between-group differences in the international normalized ratio, intraventricular hemorrhage, systolic blood pressure, or diastolic blood pressure (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Baseline characteristics of deep ICH.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Variables</bold></th>
<th valign="top" align="center"><bold>HE &#x02013;ve</bold></th>
<th valign="top" align="center"><bold>HE &#x0002B;ve</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>(<italic>N</italic> &#x0003D; 301)</bold></th>
<th valign="top" align="center"><bold>(<italic>N</italic> &#x0003D; 159)</bold></th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="4"><bold>Demographic</bold></td>
</tr>
<tr>
<td valign="top" align="left">Age, years, mean (SD)</td>
<td valign="top" align="center">60.4 (12.2)</td>
<td valign="top" align="center">59.7 (13.1)</td>
<td valign="top" align="center">0.526</td>
</tr>
<tr>
<td valign="top" align="left">Sex, male, n (%)</td>
<td valign="top" align="center">200 (66.4)</td>
<td valign="top" align="center">109 (68.6)</td>
<td valign="top" align="center">0.647</td>
</tr>
<tr>
<td valign="top" align="left" colspan="4"><bold>Medical history</bold>, <italic><bold>n</bold></italic> <bold>(%)</bold></td>
</tr>
<tr>
<td valign="top" align="left">Prior ICH</td>
<td valign="top" align="center">26 (8.6)</td>
<td valign="top" align="center">14 (8.8)</td>
<td valign="top" align="center">0.952</td>
</tr>
<tr>
<td valign="top" align="left">Ischemic stroke</td>
<td valign="top" align="center">26 (8.6)</td>
<td valign="top" align="center">23 (14.5)</td>
<td valign="top" align="center">0.054</td>
</tr>
<tr>
<td valign="top" align="left">Hypertension</td>
<td valign="top" align="center">214 (71.1)</td>
<td valign="top" align="center">111 (69.8)</td>
<td valign="top" align="center">0.773</td>
</tr>
<tr>
<td valign="top" align="left">Diabetes mellitus</td>
<td valign="top" align="center">23 (7.6)</td>
<td valign="top" align="center">20 (12.6)</td>
<td valign="top" align="center">0.084</td>
</tr>
<tr>
<td valign="top" align="left" colspan="4"><bold>Clinical features</bold></td>
</tr>
<tr>
<td valign="top" align="left">Alcohol, <italic>n</italic> (%)</td>
<td valign="top" align="center">93 (30.9)</td>
<td valign="top" align="center">53 (33.3)</td>
<td valign="top" align="center">0.593</td>
</tr>
<tr>
<td valign="top" align="left">Smoking, <italic>n</italic> (%)</td>
<td valign="top" align="center">93 (30.9)</td>
<td valign="top" align="center">49 (30.8)</td>
<td valign="top" align="center">0.986</td>
</tr>
<tr>
<td valign="top" align="left">INR, median (IQR)</td>
<td valign="top" align="center">1.0 [0.9&#x02013;1.0]</td>
<td valign="top" align="center">1.0 [0.9&#x02013;1.0]</td>
<td valign="top" align="center">0.406</td>
</tr>
<tr>
<td valign="top" align="left">SBP, mmHg, mean (SD)</td>
<td valign="top" align="center">184.4 (29.8)</td>
<td valign="top" align="center">186.8 (31.1)</td>
<td valign="top" align="center">0.421</td>
</tr>
<tr>
<td valign="top" align="left">DBP, mmHg, mean (SD)</td>
<td valign="top" align="center">99.9 (17.4)</td>
<td valign="top" align="center">101.5 (16.7)</td>
<td valign="top" align="center">0.366</td>
</tr>
<tr>
<td valign="top" align="left">Admission GCS, median (IQR)</td>
<td valign="top" align="center">12 [10&#x02013;14]</td>
<td valign="top" align="center">11 [7&#x02013;13]</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Time from onset to CT, hours, median (IQR)</td>
<td valign="top" align="center">2.4 [1.5&#x02013;3.7]</td>
<td valign="top" align="center">1.9 [1.2&#x02013;3.0]</td>
<td valign="top" align="center">0.024</td>
</tr>
<tr>
<td valign="top" align="left" colspan="4"><bold>Radiographic features</bold></td>
</tr>
<tr>
<td valign="top" align="left">Baseline ICH volume, mL, median (IQR)</td>
<td valign="top" align="center">12.3 [6.6&#x02013;20.5]</td>
<td valign="top" align="center">16.7 [8.6&#x02013;30.1]</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">IVH, n (%)</td>
<td valign="top" align="center">97 (32.2)</td>
<td valign="top" align="center">58 (36.5)</td>
<td valign="top" align="center">0.359</td>
</tr>
<tr>
<td valign="top" align="left" colspan="4"><bold>Involved locations</bold>, <italic><bold>n</bold></italic> <bold>(%)</bold></td>
</tr>
<tr>
<td valign="top" align="left">GP/P</td>
<td valign="top" align="center">211 (70.1)</td>
<td valign="top" align="center">116 (73.0)</td>
<td valign="top" align="center">0.520</td>
</tr>
<tr>
<td valign="top" align="left">EC</td>
<td valign="top" align="center">112 (37.2)</td>
<td valign="top" align="center">86 (54.1)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Caudate head</td>
<td valign="top" align="center">9 (3.0)</td>
<td valign="top" align="center">11 (6.9)</td>
<td valign="top" align="center">0.049</td>
</tr>
<tr>
<td valign="top" align="left">ALIC</td>
<td valign="top" align="center">25 (8.3)</td>
<td valign="top" align="center">28 (17.6)</td>
<td valign="top" align="center">0.003</td>
</tr>
<tr>
<td valign="top" align="left">PLIC</td>
<td valign="top" align="center">128 (42.5)</td>
<td valign="top" align="center">109 (68.6)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Thalamus</td>
<td valign="top" align="center">103 (34.2)</td>
<td valign="top" align="center">53 (33.3)</td>
<td valign="top" align="center">0.849</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>HE, hematoma expansion; &#x02013;ve, negative; &#x0002B;ve, positive; SBP, systolic blood pressure; DBP, diastolic blood pressure; GCS, Glasgow Coma Scale; CT, computed tomography; IVH, intraventricular hemorrhage; INR, international normalized ratio; ICH, intracerebral hemorrhage; GP/P, globus pallidus/putamen; EC, external capsule; ALIC, anterior limb of the internal capsule; PLIC, posterior limb of the internal capsule; SD, standard deviation; IQR, interquartile range</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>The involved anatomic sites in deep ICH included 15 single or multiple combinations. The most frequent patterns were involvement of the PLIC and thalamus (<italic>n</italic> = 90), GP/P alone (<italic>n</italic> = 86), GP/P, EC, and PLIC (<italic>n</italic> = 82), and GP/P and EC (<italic>n</italic> = 63). Details of the most frequent patterns of deep ICH are shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>. The analysis of deep ICH locations revealed that involvement of the EC, ALIC, and PLIC was more prevalent in the group with HE (<italic>p</italic> &#x0003C; 0.05), whereas involvement of the other sites did not differ between groups (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Graphic representation of the extent of deep hematoma involvement on non-contrast CT. Deep hematoma involving the PLIC was seen as early as 3.4 h following neurological deficits <bold>(A)</bold>, with progressive expansion over the subsequent 23.1 h <bold>(B)</bold>. Baseline CT showed a hematoma volume of 9.81 mL <bold>(C)</bold>, whereas the volume was 20.65 mL at the follow-up CT <bold>(D)</bold>. PLIC, posterior limb of the internal capsule.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fneur-12-749931-g0001.tif"/>
</fig>
</sec>
<sec>
<title>Association Between Involved Locations and HE</title>
<p>In the crude model without adjustment, EC, ALIC, and PLIC involvement were correlated with HE [<italic>OR</italic> = 1.99 (95% CIs = 1.35&#x02013;2.94); <italic>OR</italic> = 2.36 (95% CIs = 1.32&#x02013;4.21), and <italic>OR</italic> = 2.95 (95% CIs = 1.96&#x02013;4.42), respectively]. After minimal adjustments for sex and age, multivariable logistic regression revealed that the EC (<italic>OR</italic> = 1.98; and 95% <italic>CIs</italic> = 1.34&#x02013;2.94; <italic>p</italic> &#x0003C; 0.001), ALIC (<italic>OR</italic> = 2.37; 95% <italic>CIs</italic> = 1.33&#x02013;4.23; <italic>p</italic> = 0.003), and PLIC (<italic>OR</italic> = 3.00; 95% <italic>CIs</italic> = 1.99&#x02013;4.51; <italic>p</italic> &#x0003C; 0.001) were associated with HE. In fully adjusted models for sex, age, IVH, admission GCS score, baseline ICH volume, and time from onset to CT, the EC and ALIC were not predictive of HE, whereas the PLIC (<italic>OR</italic> = 2.73; 95% <italic>CIs</italic> = 1.75&#x02013;4.26; <italic>p</italic> &#x0003C; 0.001) remained predictive of HE (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Crude and adjusted multivariable logistic regression analysis for the association between deep ICH sites of involvement and hematoma expansion.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Variables</bold></th>
<th valign="top" align="center"><bold>No</bold>.</th>
<th valign="top" align="center"><bold>Crude model</bold></th>
<th valign="top" align="center"><bold><italic>p-</italic>value</bold></th>
<th valign="top" align="center"><bold>Minimally adjusted model</bold></th>
<th valign="top" align="center"><bold><italic>p-</italic>value</bold></th>
<th valign="top" align="center"><bold>Fully adjusted model</bold></th>
<th valign="top" align="center"><bold><italic>p-</italic>value</bold></th>
</tr>
<tr>
<th/>
<th/>
<th valign="top" align="center"><bold>OR (95% CI)</bold></th>
<th/>
<th valign="top" align="center"><bold>OR (95% CI)</bold></th>
<th/>
<th valign="top" align="center"><bold>OR (95% CI)</bold></th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">GP/P</td>
<td valign="top" align="center">327</td>
<td valign="top" align="center">1.15 (0.75, 1.77)</td>
<td valign="top" align="center">0.521</td>
<td valign="top" align="center">1.13 (0.73, 1.74)</td>
<td valign="top" align="center">0.596</td>
<td valign="top" align="center">0.54 (0.29, 0.99)</td>
<td valign="top" align="center">0.047</td>
</tr>
<tr>
<td valign="top" align="left">EC</td>
<td valign="top" align="center">198</td>
<td valign="top" align="center">1.99 (1.35, 2.94)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
<td valign="top" align="center">1.98 (1.34, 2.94)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
<td valign="top" align="center">1.31 (0.77, 2.22)</td>
<td valign="top" align="center">0.316</td>
</tr>
<tr>
<td valign="top" align="left">Caudate head</td>
<td valign="top" align="center">20</td>
<td valign="top" align="center">2.41 (0.98, 5.95)</td>
<td valign="top" align="center">0.056</td>
<td valign="top" align="center">2.50 (1.01, 6.18)</td>
<td valign="top" align="center">0.048</td>
<td valign="top" align="center">1.24 (0.44, 3.44)</td>
<td valign="top" align="center">0.685</td>
</tr>
<tr>
<td valign="top" align="left">ALIC</td>
<td valign="top" align="center">53</td>
<td valign="top" align="center">2.36 (1.32, 4.21)</td>
<td valign="top" align="center">0.004</td>
<td valign="top" align="center">2.37 (1.33, 4.23)</td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">1.24 (0.63, 2.45)</td>
<td valign="top" align="center">0.530</td>
</tr>
<tr>
<td valign="top" align="left">PLIC</td>
<td valign="top" align="center">237</td>
<td valign="top" align="center">2.95 (1.96, 4.42)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
<td valign="top" align="center">3.00 (1.99, 4.51)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
<td valign="top" align="center">2.73 (1.75, 4.26)</td>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Thalamus</td>
<td valign="top" align="center">156</td>
<td valign="top" align="center">0.96 (0.64, 1.44)</td>
<td valign="top" align="center">0.849</td>
<td valign="top" align="center">0.99 (0.65, 1.49)</td>
<td valign="top" align="center">0.946</td>
<td valign="top" align="center">1.76 (0.98, 3.17)</td>
<td valign="top" align="center">0.060</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Crude model: Without adjustment</italic>.</p>
<p><italic>Minimally adjusted model: Covariates were adjusted for age, sex</italic>.</p>
<p><italic>Fully adjusted model: Covariates were adjusted for age, sex, IVH, admission GCS score, Baseline ICH volume, and time from onset to CT</italic>.</p>
<p><italic>OR, odds ratio; CI, confidence interval; GP/P, globus pallidus/putamen; EC, external capsule; ALIC, anterior limb of the internal capsule; PLIC, posterior limb of the internal capsule</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Subgroup Analyses</title>
<p>To elucidate the suitability and applicability of the PLIC predicting HE among different potential clinical confounders, we conducted subgroup analyses. The impact of the PLIC on HE was not affected by age, sex, time from onset to CT, admission GCS score, IVH, or baseline ICH volume (value of p for interaction = 0.073&#x02013;0.986; <xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Subgroup analysis of the association between hematoma expansion and the PLIC. OR, odds ratio; CI, confidence interval; GCS, Glasgow Coma Scale; IVH, intraventricular hemorrhage; CT, computed tomography; ICH, intracerebral hemorrhage.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fneur-12-749931-g0002.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this relatively large retrospective multi-center study, we demonstrated a strong relationship between anatomic zones and HE in patients with deep ICH. Previously identified vital factors related to HE are larger baseline hematoma volumes, shorter time from onset to initial CT, lower GCS score at admission, and IVH (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). When controlling for these potential confounders in the multivariable logistic regression, we found that any deep ICH that affects the PLIC is still a vigorous driver of HE alone. Similarly, subgroup analyses including relevant variables revealed a similar result.</p>
<p>Many previous studies have focused on the occurrence of hematoma growth, with an emphasis on the ability to predict HE (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). That is to say, differences between deep and lobar hemorrhages, which may affect HE, were not taken into consideration. Deep hemorrhages were found to be overwhelmingly driven by hypertension, whereas cerebral amyloid angiopathy has been commonly cited as the primary reason for lobar locations, although hypertension was also a pivotal cause (<xref ref-type="bibr" rid="B12">12</xref>). In most previous studies (<xref ref-type="bibr" rid="B9">9</xref>&#x02013;<xref ref-type="bibr" rid="B11">11</xref>), the implications of hematoma heterogeneity have typically been disregarded, which means that there has been no sufficient evidence to suggest that HE is more frequently observed in deep than in lobar groups. Therefore, we did not include patients with lobar hemorrhages in the present study.</p>
<p>It is increasingly urgent and imperative to identify HE, as growing evidence has revealed that deep sites contribute to worse clinical outcomes after ICH (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B11">11</xref>). The influence of deep HE on the clinical severity is dependent on the functional integrity of impaired fiber bundles and the specific anatomic regions of lesions. Damage to pyramidal tracts caused by HE of the internal capsule not only triggers physical disability but also gives rise to subjective discomfort and distress (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). Once thalamic ICH occurs, there is a higher probability that blood will leak into the ventricles and that massive bleeding will add pressure to the brainstem, resulting in acute obstructive hydrocephalus and even rapid death (<xref ref-type="bibr" rid="B22">22</xref>). However, previous investigations into the latent association between deep locations and HE have been limited. Consequently, identification of the risk of HE based on the involvement of specific areas is critical for stratifying patients for therapeutic interventions.</p>
<p>The precise mechanism underlying the correlation between PLIC involvement and HE, however, remains unclear. It possible that specific anatomic characteristics provide the foundation for hemorrhagic progression. Since projection fibers are primarily located in the internal capsule, and are most abundant in the PLIC (<xref ref-type="bibr" rid="B23">23</xref>), blood to the PLIC region is supplied by branches from multiple arteries (<xref ref-type="bibr" rid="B24">24</xref>). One large study has also indicated that hematoma involving the PLIC is strongly correlated with a worse prognosis (<xref ref-type="bibr" rid="B13">13</xref>), and that HE itself is a critical predictor of ICH outcome (<xref ref-type="bibr" rid="B3">3</xref>), which underlines the potential link between the PLIC and HE. An additional possible explanation for our novel finding is that the comparatively larger contact area between the PLIC and lateral ventricle increases the risk of HE. Hematoma involving the PLIC might result in higher pressures, with effects spreading to the lateral ventricle. Deng et al. (<xref ref-type="bibr" rid="B25">25</xref>) also proposed that hematoma ventricle distance can predict poor outcomes in ICH, which is well-aligned with the current findings. It is puzzling that the thalamus, which is closer to the lateral ventricles, should theoretically be more prone to HE, but we found no evidence for this. Neisewander et al. (<xref ref-type="bibr" rid="B26">26</xref>) divided thalamic hemorrhage into six parts, and they found that posterior and lateral bleeds were less likely to cause neurological deterioration than global bleeds. However, our study is only a crude analysis of the involvement of thalamic hemorrhage, which may have obscured the natural conditions. As such, future studies focusing on the influence of specific regions of the thalamus on hematoma growth are warranted.</p>
<p>Our study has several strengths. We used data from three centers, which better exemplifies the real-world heterogeneity, with much more diverse and representative cases of ICH than single-center studies. Another advantage of our research lies in the accurate measurement of ICH volumes based on three-dimensional analysis, which reduces measurement errors caused by irregular hematoma and intraventricular hemorrhage.</p>
<p>However, the current investigation has some limitations. First, The patients were recruited retrospectively from the existing database, and so selection bias cannot be ruled out. Second, it is difficult to estimate the precise time of onset since neurological symptoms are found suddenly by eyewitness statements. If the actual onset was not witnessed, the time of onset of ICH symptoms was defined as the moment at which the patient was last seen to be normal, which may have resulted in recall bias. Finally, follow-up CT scans for a small portion of patients are determined by the actual clinical situation, which may underestimate the detection rate of real HE.</p>
</sec>
<sec sec-type="conclusions" id="s5">
<title>Conclusions</title>
<p>For patient with deep ICH, we suggest that more attention be paid to the hematoma location, because there is a strong association between hemorrhage involving the posterior limb of the internal capsule and HE.</p>
</sec>
<sec sec-type="data-availability" id="s6">
<title>Data Availability Statement</title>
<p>The datasets presented in this article are not readily available because requests to access them must first be approved by the stroke centers that provided them. Requests to access the datasets should be directed to Yong-Qiang Yu, <email>cjr.yuyongqiang&#x00040;vip.163.com</email>.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>The Ethical Review Committees of Xiangyang Central Hospital, the First Affiliated Hospital of Anhui Medical University, and the Second Hospital of Anhui Medical University reviewed and approved this study. The data from three centers were anonymous and processed in a confidential manner. The request for written informed consent was waived due to the retrospective design of the present study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>LS and Y-QY involved in the study design, interpretation of data, and study supervision. LS contributed to data collection, data analysis, data management, and manuscript writing. T-TG contributed to the study design, manuscript review, and proofreading. X-MQ contributed to the data analysis and proofreading. HZ, L-SW, D-FT, HC, and H-BW responsible for data collection. Y-FF contributed to data analysis. H-QM involved in the data analysis and grammar. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>This study was supported by grants from the National Natural Science Foundation of China, Grant/Award Numbers: 81771817, 81801679, and 82071905.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack><p>We acknowledge and thank our study participants.</p>
</ack>
<sec sec-type="supplementary-material" id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fneur.2021.749931/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fneur.2021.749931/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.DOCX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><collab>GBD 2019 Diseases and Injuries Collaborators</collab></person-group>. <article-title>Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019</article-title>. <source>Lancet.</source> (<year>2020</year>) <volume>396</volume>:<fpage>1204</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30925-9</pub-id><pub-id pub-id-type="pmid">33069326</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Asch</surname> <given-names>CJ</given-names></name> <name><surname>Luitse</surname> <given-names>MJ</given-names></name> <name><surname>Rinkel</surname> <given-names>GJ</given-names></name> <name><surname>van der Tweel</surname> <given-names>I</given-names></name> <name><surname>Algra</surname> <given-names>A</given-names></name> <name><surname>Klijn</surname> <given-names>CJ</given-names></name></person-group>. <article-title>Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis</article-title>. <source>Lancet Neurol.</source> (<year>2010</year>) <volume>9</volume>:<fpage>167</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(09)70340-0</pub-id><pub-id pub-id-type="pmid">20056489</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brouwers</surname> <given-names>HB</given-names></name> <name><surname>Chang</surname> <given-names>Y</given-names></name> <name><surname>Falcone</surname> <given-names>GJ</given-names></name> <name><surname>Cai</surname> <given-names>X</given-names></name> <name><surname>Ayres</surname> <given-names>AM</given-names></name> <name><surname>Battey</surname> <given-names>TW</given-names></name> <etal/></person-group>. <article-title>Predicting hematoma expansion after primary intracerebral hemorrhage</article-title>. <source>JAMA Neurol</source>. (<year>2014</year>) <volume>71</volume>:<fpage>158</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2013.5433</pub-id><pub-id pub-id-type="pmid">24366060</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dowlatshahi</surname> <given-names>D</given-names></name> <name><surname>Demchuk</surname> <given-names>AM</given-names></name> <name><surname>Flaherty</surname> <given-names>ML</given-names></name> <name><surname>Ali</surname> <given-names>M</given-names></name> <name><surname>Lyden</surname> <given-names>PL</given-names></name> <name><surname>Smith</surname> <given-names>EE</given-names></name> <etal/></person-group>. <article-title>Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes</article-title>. <source>Neurology.</source> (<year>2011</year>) <volume>76</volume>:<fpage>1238</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3182143317</pub-id><pub-id pub-id-type="pmid">21346218</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delcourt</surname> <given-names>C</given-names></name> <name><surname>Huang</surname> <given-names>Y</given-names></name> <name><surname>Arima</surname> <given-names>H</given-names></name> <name><surname>Chalmers</surname> <given-names>J</given-names></name> <name><surname>Davis</surname> <given-names>SM</given-names></name> <name><surname>Heeley</surname> <given-names>EL</given-names></name> <etal/></person-group>. <article-title>Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study</article-title>. <source>Neurology.</source> (<year>2012</year>) <volume>79</volume>:<fpage>314</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e318260cbba</pub-id><pub-id pub-id-type="pmid">22744655</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sprigg</surname> <given-names>N</given-names></name> <name><surname>Flaherty</surname> <given-names>K</given-names></name> <name><surname>Appleton</surname> <given-names>JP</given-names></name> <name><surname>Al-Shahi Salman</surname> <given-names>R</given-names></name> <name><surname>Bereczki</surname> <given-names>D</given-names></name> <name><surname>Beridze</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial</article-title>. <source>Lancet.</source> (<year>2018</year>) <volume>391</volume>:<fpage>2107</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)31033-X</pub-id><pub-id pub-id-type="pmid">29778325</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leasure</surname> <given-names>AC</given-names></name> <name><surname>Qureshi</surname> <given-names>AI</given-names></name> <name><surname>Murthy</surname> <given-names>SB</given-names></name> <name><surname>Kamel</surname> <given-names>H</given-names></name> <name><surname>Goldstein</surname> <given-names>JN</given-names></name> <name><surname>Woo</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Association of intensive blood pressure reduction with risk of hematoma expansion in patients with deep intracerebral hemorrhage</article-title>. <source>JAMA Neurol.</source> (<year>2019</year>) <volume>76</volume>:<fpage>949</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2019.1141</pub-id><pub-id pub-id-type="pmid">31081862</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brouwers</surname> <given-names>HB</given-names></name> <name><surname>Greenberg</surname> <given-names>SM</given-names></name></person-group>. <article-title>Hematoma expansion following acute intracerebral hemorrhage</article-title>. <source>Cerebrovasc Dis.</source> (<year>2013</year>) <volume>35</volume>:<fpage>195</fpage>&#x02013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1159/000346599</pub-id><pub-id pub-id-type="pmid">27055512</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roh</surname> <given-names>D</given-names></name> <name><surname>Boehme</surname> <given-names>A</given-names></name> <name><surname>Young</surname> <given-names>C</given-names></name> <name><surname>Roth</surname> <given-names>W</given-names></name> <name><surname>Gutierrez</surname> <given-names>J</given-names></name> <name><surname>Flaherty</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Hematoma expansion is more frequent in deep than lobar intracerebral hemorrhage</article-title>. <source>Neurology.</source> (<year>2020</year>) <volume>95</volume>:<fpage>e3386</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000010990</pub-id><pub-id pub-id-type="pmid">33219144</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sembill</surname> <given-names>JA</given-names></name> <name><surname>Kuramatsu</surname> <given-names>JB</given-names></name> <name><surname>Gerner</surname> <given-names>ST</given-names></name> <name><surname>Spr&#x000FC;gel</surname> <given-names>MI</given-names></name> <name><surname>Roeder</surname> <given-names>SS</given-names></name> <name><surname>Mad&#x0017D;ar</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage</article-title>. <source>Ann Clin Transl Neurol.</source> (<year>2020</year>) <volume>7</volume>:<fpage>363</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1002/acn3.51001</pub-id><pub-id pub-id-type="pmid">32133793</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roh</surname> <given-names>D</given-names></name> <name><surname>Sun</surname> <given-names>CH</given-names></name> <name><surname>Murthy</surname> <given-names>S</given-names></name> <name><surname>Elkind</surname> <given-names>M</given-names></name> <name><surname>Bruce</surname> <given-names>SS</given-names></name> <name><surname>Melmed</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Hematoma expansion differences in lobar and deep primary intracerebral hemorrhage</article-title>. <source>Neurocrit Care.</source> (<year>2019</year>) <volume>31</volume>:<fpage>40</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1007/s12028-018-00668-2</pub-id><pub-id pub-id-type="pmid">30756318</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cordonnier</surname> <given-names>C</given-names></name> <name><surname>Demchuk</surname> <given-names>A</given-names></name> <name><surname>Ziai</surname> <given-names>W</given-names></name> <name><surname>Anderson</surname> <given-names>CS</given-names></name></person-group>. <article-title>Intracerebral haemorrhage: current approaches to acute management</article-title>. <source>Lancet.</source> (<year>2018</year>) <volume>392</volume>:<fpage>1257</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)31878-6</pub-id><pub-id pub-id-type="pmid">30319113</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delcourt</surname> <given-names>C</given-names></name> <name><surname>Sato</surname> <given-names>S</given-names></name> <name><surname>Zhang</surname> <given-names>S</given-names></name> <name><surname>Sandset</surname> <given-names>EC</given-names></name> <name><surname>Zheng</surname> <given-names>D</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>Intracerebral hemorrhage location and outcome among INTERACT2 participants</article-title>. <source>Neurology.</source> (<year>2017</year>) <volume>88</volume>:<fpage>1408</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000003771</pub-id><pub-id pub-id-type="pmid">28235817</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yogendrakumar</surname> <given-names>V</given-names></name> <name><surname>Ramsay</surname> <given-names>T</given-names></name> <name><surname>Fergusson</surname> <given-names>DA</given-names></name> <name><surname>Demchuk</surname> <given-names>AM</given-names></name> <name><surname>Aviv</surname> <given-names>RI</given-names></name> <name><surname>Rodriguez-Luna</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Redefining hematoma expansion with the inclusion of intraventricular hemorrhage growth</article-title>. <source>Stroke.</source> (<year>2020</year>) <volume>51</volume>:<fpage>1120</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.119.027451</pub-id><pub-id pub-id-type="pmid">32078498</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yogendrakumar</surname> <given-names>V</given-names></name> <name><surname>Ramsay</surname> <given-names>T</given-names></name> <name><surname>Fergusson</surname> <given-names>D</given-names></name> <name><surname>Demchuk</surname> <given-names>AM</given-names></name> <name><surname>Aviv</surname> <given-names>RI</given-names></name> <name><surname>Rodriguez-Luna</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>New and expanding ventricular hemorrhage predicts poor outcome in acute intracerebral hemorrhage</article-title>. <source>Neurology.</source> (<year>2019</year>) <volume>93</volume>:<fpage>e879</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000008007</pub-id><pub-id pub-id-type="pmid">31371565</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yaghi</surname> <given-names>S</given-names></name> <name><surname>Dibu</surname> <given-names>J</given-names></name> <name><surname>Achi</surname> <given-names>E</given-names></name> <name><surname>Patel</surname> <given-names>A</given-names></name> <name><surname>Samant</surname> <given-names>R</given-names></name> <name><surname>Hinduja</surname> <given-names>A</given-names></name></person-group>. <article-title>Hematoma expansion in spontaneous intracerebral hemorrhage: predictors and outcome</article-title>. <source>Int J Neurosci.</source> (<year>2014</year>) <volume>124</volume>:<fpage>890</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.3109/00207454.2014.887716</pub-id><pub-id pub-id-type="pmid">24472073</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Q</given-names></name> <name><surname>Li</surname> <given-names>R</given-names></name> <name><surname>Zhao</surname> <given-names>LB</given-names></name> <name><surname>Yang</surname> <given-names>XM</given-names></name> <name><surname>Yang</surname> <given-names>WS</given-names></name> <name><surname>Deng</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Intraventricular hemorrhage growth: definition, prevalence and association with hematoma expansion and prognosis</article-title>. <source>Neurocrit Care.</source> (<year>2020</year>) <volume>33</volume>:<fpage>732</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s12028-020-00958-8</pub-id><pub-id pub-id-type="pmid">32219678</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname> <given-names>XN</given-names></name> <name><surname>Deng</surname> <given-names>L</given-names></name> <name><surname>Yang</surname> <given-names>WS</given-names></name> <name><surname>Wei</surname> <given-names>X</given-names></name> <name><surname>Li</surname> <given-names>Q</given-names></name></person-group>. <article-title>Computed tomography imaging predictors of intracerebral hemorrhage expansion</article-title>. <source>Curr Neurol Neurosci Rep.</source> (<year>2021</year>) <volume>21</volume>:<fpage>22</fpage>. <pub-id pub-id-type="doi">10.1007/s11910-021-01108-z</pub-id><pub-id pub-id-type="pmid">33710468</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poli</surname> <given-names>L</given-names></name> <name><surname>Leuci</surname> <given-names>E</given-names></name> <name><surname>Costa</surname> <given-names>P</given-names></name> <name><surname>De Giuli</surname> <given-names>V</given-names></name> <name><surname>Caria</surname> <given-names>F</given-names></name> <name><surname>Candeloro</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Validation and comparison of noncontrast ct scores to predict intracerebral hemorrhage expansion</article-title>. <source>Neurocrit Care.</source> (<year>2020</year>) <volume>32</volume>:<fpage>804</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1007/s12028-019-00797-2</pub-id><pub-id pub-id-type="pmid">31342451</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Wei</surname> <given-names>XH</given-names></name> <name><surname>Liu</surname> <given-names>YK</given-names></name> <name><surname>Chen</surname> <given-names>LS</given-names></name> <name><surname>Zhu</surname> <given-names>ZQ</given-names></name> <name><surname>Hou</surname> <given-names>SY</given-names></name> <etal/></person-group>. <article-title>Evidence of motor injury due to damaged corticospinal tract following acute hemorrhage in the basal ganglia region</article-title>. <source>Sci Rep.</source> (<year>2020</year>) <volume>10</volume>:<fpage>16346</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-73305-8</pub-id><pub-id pub-id-type="pmid">33004960</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Puig</surname> <given-names>J</given-names></name> <name><surname>Blasco</surname> <given-names>G</given-names></name> <name><surname>Terce&#x000F1;o</surname> <given-names>M</given-names></name> <name><surname>Daunis-I-Estadella</surname> <given-names>P</given-names></name> <name><surname>Schlaug</surname> <given-names>G</given-names></name> <name><surname>Hernandez-Perez</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Predicting motor outcome in acute intracerebral hemorrhage</article-title>. <source>Am J Neuroradiol</source>. (<year>2019</year>) <volume>40</volume>:<fpage>769</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A6038</pub-id><pub-id pub-id-type="pmid">31000524</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arboix</surname> <given-names>A</given-names></name> <name><surname>Rodr&#x000ED;guez-Aguilar</surname> <given-names>R</given-names></name> <name><surname>Oliveres</surname> <given-names>M</given-names></name> <name><surname>Comes</surname> <given-names>E</given-names></name> <name><surname>Garc&#x000ED;a-Eroles</surname> <given-names>L</given-names></name> <name><surname>Massons</surname> <given-names>J</given-names></name></person-group>. <article-title>Thalamic haemorrhage vs. internal capsule-basal ganglia haemorrhage: clinical profile and predictors of in-hospital mortality</article-title>. <source>BMC Neurol.</source> (<year>2007</year>) <volume>7</volume>:<fpage>32</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2377-7-32</pub-id><pub-id pub-id-type="pmid">17919332</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kurabe</surname> <given-names>S</given-names></name> <name><surname>Okamoto</surname> <given-names>K</given-names></name> <name><surname>Suzuki</surname> <given-names>K</given-names></name> <name><surname>Matsuzawa</surname> <given-names>H</given-names></name> <name><surname>Watanabe</surname> <given-names>M</given-names></name> <name><surname>Suzuki</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>The posterior limb of the internal capsule as the subcortical transitional zone of the anterior and posterior circulations: insights from human 7T MRI</article-title>. <source>Cerebrovasc Dis.</source> (<year>2016</year>) <volume>41</volume>:<fpage>256</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1159/000443538</pub-id><pub-id pub-id-type="pmid">26828207</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Djuleji&#x00107;</surname> <given-names>V</given-names></name> <name><surname>Marinkovi&#x00107;</surname> <given-names>S</given-names></name> <name><surname>Georgievski</surname> <given-names>B</given-names></name> <name><surname>Stijak</surname> <given-names>L</given-names></name> <name><surname>Aksi&#x00107;</surname> <given-names>M</given-names></name> <name><surname>Pu&#x00161;ka&#x00161;</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Clinical significance of blood supply to the internal capsule and basal ganglia</article-title>. <source>J Clin Neurosci.</source> (<year>2016</year>) <volume>25</volume>:<fpage>19</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocn.2015.04.034</pub-id><pub-id pub-id-type="pmid">26596401</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname> <given-names>L</given-names></name> <name><surname>Zhang</surname> <given-names>YD</given-names></name> <name><surname>Ji</surname> <given-names>JW</given-names></name> <name><surname>Yang</surname> <given-names>WS</given-names></name> <name><surname>Wei</surname> <given-names>X</given-names></name> <name><surname>Shen</surname> <given-names>YQ</given-names></name> <etal/></person-group>. <article-title>Hematoma ventricle distance on computed tomography predicts poor outcome in intracerebral hemorrhage</article-title>. <source>Front Neurosci.</source> (<year>2020</year>) <volume>14</volume>:<fpage>589050</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2020.589050</pub-id><pub-id pub-id-type="pmid">33328859</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neisewander</surname> <given-names>BL</given-names></name> <name><surname>Hu</surname> <given-names>K</given-names></name> <name><surname>Tan</surname> <given-names>Z</given-names></name> <name><surname>Zakrzewski</surname> <given-names>J</given-names></name> <name><surname>Kheirkhah</surname> <given-names>P</given-names></name> <name><surname>Kumar</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Location of thalamic hemorrhage impacts prognosis</article-title>. <source>World Neurosurg</source>. (<year>2018</year>) <volume>116</volume>:<fpage>e525</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.wneu.2018.05.026</pub-id><pub-id pub-id-type="pmid">29772365</pub-id></citation></ref>
</ref-list>
</back>
</article>